Blue Earth Diagnostics clinical trials
Acquired by Bracco, Aug 1, 2019 · source ↗
The registry lists 12 studies whose lead sponsor is Blue Earth Diagnostics. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 7, 2026.
Before and after it joined Bracco
- First submitted before Blue Earth Diagnostics became part of Bracco
- 4
- First submitted after Blue Earth Diagnostics became part of Bracco
- 8
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Blue Earth Diagnostics12 studies
Something wrong with this grouping? Tell us on the Bracco page.
Studies
Recruiting first, then most recently updated. Showing 12 of 12. All Bracco studies →
- Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceRecruitingNCT07569926Phase 4
Sponsor listed in the registry: Blue Earth Diagnostics · First submitted after Blue Earth Diagnostics became part of Bracco
- [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology IndicationsRecruitingNCT07702292Phase 2
Sponsor listed in the registry: Blue Earth Diagnostics · First submitted after Blue Earth Diagnostics became part of Bracco
- [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology IndicationsRecruitingNCT07432633Phase 1/2
Sponsor listed in the registry: Blue Earth Diagnostics · First submitted after Blue Earth Diagnostics became part of Bracco
- Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical ProstatectomyCompletedNCT06604442Phase 4
Sponsor listed in the registry: Blue Earth Diagnostics · First submitted after Blue Earth Diagnostics became part of Bracco
- Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate CancerCompletedNCT03995888Phase 1
Sponsor listed in the registry: Blue Earth Diagnostics · First submitted before Blue Earth Diagnostics became part of Bracco
- Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer RecurrenceCompletedNCT04186845Phase 3
Sponsor listed in the registry: Blue Earth Diagnostics · First submitted after Blue Earth Diagnostics became part of Bracco
- Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain MetastasesCompletedNCT04410133Phase 3
Sponsor listed in the registry: Blue Earth Diagnostics · First submitted after Blue Earth Diagnostics became part of Bracco
- Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)CompletedNCT04410367Phase 2
Sponsor listed in the registry: Blue Earth Diagnostics · First submitted after Blue Earth Diagnostics became part of Bracco
- Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.CompletedNCT04186819Phase 3
Sponsor listed in the registry: Blue Earth Diagnostics · First submitted after Blue Earth Diagnostics became part of Bracco
- Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcerCompletedNCT02578940Phase 3
Sponsor listed in the registry: Blue Earth Diagnostics · First submitted before Blue Earth Diagnostics became part of Bracco
- 18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer TreatmentCompletedNCT02680041Phase 3
Sponsor listed in the registry: Blue Earth Diagnostics · First submitted before Blue Earth Diagnostics became part of Bracco
- Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)CompletedNCT02443571
Sponsor listed in the registry: Blue Earth Diagnostics · First submitted before Blue Earth Diagnostics became part of Bracco